Wayne’s Egalet and the National Lacrosse League, which is headquartered in Conshohocken, have joined forces to promote the use of non-opioid pain treatments, writes John George for the Philadelphia Business Journal.
The two-year agreement will focus on providing physicians with education on pain management.
Among the planned activities is a product symposium that will be held at the 2017 NLL Medical Summit. There physicians will be educated on how to help treat pain with non-steroid, non-narcotic drugs.
Egalet will also present its Sprix nasal spray, an FDA-approved, non-steroid, anti-inflammatory drug. Sprix is used by adults for short-term management of moderate to moderately-severe pain that requires special treatment.
“Box lacrosse is a fast-paced and physical sport,” said NLL Commissioner Nick Sakiewicz. “The health and safety of our players is paramount, and we’re proud to partner with Egalet.”
Pat Shea, chief commercial officer at Egalet, reaffirmed the company’s commitment to responsible pain management education.
“Together with NLL, we can help educate healthcare providers about a non-narcotic treatment option for acute pain,” said Shea.
Read more about the National Lacrosse League’s partnership with Egalet in the Philadelphia Business Journal by clicking here.